DIA

Joslin Diabetes Center to build translational center for the cure of diabetes

Thursday, January 26, 2012 12:48 PM

Boston-based Joslin Diabetes Center has received a $5 million grant from the Massachusetts Life Sciences Center. The grant is among the highest amounts ever received to support diabetes research in Massachusetts.

More... »

Aria Diagnostic launches study of non-invasive prenatal test

Wednesday, January 18, 2012 12:04 PM

As Down syndrome becomes an increasing concern, Aria Diagnostics is launching a comparative study of a non-invasive prenatal test to detect Trisomy 21 (associated with Down synrome) and the standard first-trimester screening test.

More... »

KalVista, JDRF partner to treat diabetic eye disease

Wednesday, January 11, 2012 11:23 AM

KalVista Pharmaceuticals has enlisted the help of the Juvenile Diabetes Research Foundation (JDRF) to further a novel approach KalVista is developing to preserve vision and slow progression of eye disease in type 1 diabetics.

More... »

Circadian launches phase I cancer trial

Monday, January 9, 2012 01:59 PM

Circadian Technologies, a biologic drug developer, has launched the first phase I clinical trial of VGX-100, its fully human monoclonal antibody against the human VEGF-C protein.

More... »

Gong joins Premier Research

Wednesday, December 21, 2011 12:32 PM

Premier Research Group has named Hua Gong executive director of medical diagnostics. In this role, Gong will be responsible for overseeing the in vitro diagnostics (IVD) business within the company.

More... »

Roche acquires Verum Diagnostica

Monday, December 5, 2011 01:30 PM

Roche has signed an agreement under which it will acquire 100% of Verum Diagnostica, based in Munich, Germany. Verum Diagnostica is a leading company in platelet function testing, the fastest-growing field in the coagulation diagnostics market.

More... »

NASA signs patent license agreement for Atherosclerosis treatment

Monday, December 5, 2011 12:05 PM

NASA has signed a patent license agreement that will allow a California company use of NASA-developed technology that could be used to treat hardened arteries in the heart.

More... »

Quintiles, Prodia partner to provide central lab testing in Indonesia

Thursday, December 1, 2011 12:31 PM

Quintiles has reported an expanded partnership with Jakarta-based Prodia Clinical Laboratory, through its sister company Prodia the CRO, to facilitate rapid testing of samples from patients in clinical trials in Indonesia. This will allow Quintiles’ biopharmaceutical customers to conduct clinical research in Indonesia and help establish the potential benefits of new medicines in the Indonesian population while contributing to global programs.

More... »

Pacific Urology, Diablo Valley Oncology merge launching multi-specialty practice

Monday, November 14, 2011 10:07 AM

Two private specialty medical practices have agreed to merge forming the area's first multi-specialty practice in oncology and urology as a hedge against mounting business challenges in a rapidly changing healthcare landscape.

More... »

Abcodia, Oxford Gene Technology partner to advance pancreatic cancer biomarkers

Wednesday, November 9, 2011 08:42 AM

Abcodia, a company engaged in the validation and discovery of biomarkers of cancer and other age-related diseases, and Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, have signed a collaboration aimed at improving the early detection of pancreatic cancer.

More... »